Related Experiment Video
Updated: Mar 12, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
13.1K
Perspectives for therapeutic HPV vaccine development.
Andrew Yang1, Emily Farmer1, T C Wu1,2,3,4
1Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.
Journal of Biomedical Science
|November 5, 2016
Summary
Therapeutic vaccines are being developed to treat existing human papillomavirus (HPV) infections and cancers. Targeting HPV oncoproteins E6 and E7 shows promise for effective treatment strategies against HPV-associated diseases.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Human papillomavirus (HPV) infections cause significant global health issues, including cancers.
- Existing preventative HPV vaccines do not treat established infections or lesions.
- There is a critical need for therapeutic strategies to manage HPV-related diseases.
Purpose of the Study:
- To review therapeutic HPV vaccines targeting established infections and lesions.
- To focus on clinical trial findings for therapeutic HPV vaccines.
Main Methods:
- Therapeutic vaccines aim to induce cell-mediated immunity.
- HPV oncoproteins E6 and E7 are key targets for therapeutic vaccine development.
- Review of recent clinical trials for therapeutic HPV vaccines.
Main Results:
- Progress has been made in developing novel therapeutic HPV vaccines.
- Therapeutic vaccines target HPV oncoproteins E6 and E7 for treating HPV-associated diseases.
- Recent clinical trials are evaluating the efficacy of these vaccines.
Conclusions:
- Therapeutic HPV vaccines show potential for treating existing HPV infections and diseases.
- Further research and development are necessary for widespread clinical application.
- These vaccines may become a successful future therapy for HPV-related conditions.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K